Click for best price
Drugs Based on CAR Tcell Market Size, Share 2023
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
This report contains market size and forecasts of Drugs Based on CAR T-cell in Global, including the following market information:
Global Drugs Based on CAR T-cell Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Drugs Based on CAR T-cell market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
CD19-targeted Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Drugs Based on CAR T-cell include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics and FOSUNKite, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs Based on CAR T-cell companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs Based on CAR T-cell Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Drugs Based on CAR T-cell Market Segment Percentages, by Type, 2022 (%)
CD19-targeted
BCMA-targeted
Global Drugs Based on CAR T-cell Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Drugs Based on CAR T-cell Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Multiple Myeloma
Global Drugs Based on CAR T-cell Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Drugs Based on CAR T-cell Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs Based on CAR T-cell revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs Based on CAR T-cell revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
| Report Attributes |
Report Details |
| Report Title |
Drugs Based on CAR T-cell Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs Based on CAR T-cell Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs Based on CAR T-cell Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs Based on CAR T-cell Overall Market Size
2.1 Global Drugs Based on CAR T-cell Market Size: 2022 VS 2030
2.2 Global Drugs Based on CAR T-cell Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs Based on CAR T-cell Players in Global Market
3.2 Top Global Drugs Based on CAR T-cell Companies Ranked by Revenue
3.3 Global Drugs Based on CAR T-cell Revenue by Companies
3.4 Top 3 and Top 5 Drugs Based on CAR T-cell Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs Based on CAR T-cell Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs Based on CAR T-cell Players in Global Market
3.6.1 List of Global Tier 1 Drugs Based on CAR T-cell Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs Based on CAR T-cell Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drugs Based on CAR T-cell Market Size Markets, 2022 & 2030
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type - Global Drugs Based on CAR T-cell Revenue & Forecasts
4.2.1 By Type - Global Drugs Based on CAR T-cell Revenue, 2018-2023
4.2.2 By Type - Global Drugs Based on CAR T-cell Revenue, 2023-2030
4.2.3 By Type - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs Based on CAR T-cell Market Size, 2022 & 2030
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global Drugs Based on CAR T-cell Revenue & Forecasts
5.2.1 By Application - Global Drugs Based on CAR T-cell Revenue, 2018-2023
5.2.2 By Application - Global Drugs Based on CAR T-cell Revenue, 2023-2030
5.2.3 By Application - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Drugs Based on CAR T-cell Market Size, 2022 & 2030
6.2 By Region - Global Drugs Based on CAR T-cell Revenue & Forecasts
6.2.1 By Region - Global Drugs Based on CAR T-cell Revenue, 2018-2023
6.2.2 By Region - Global Drugs Based on CAR T-cell Revenue, 2023-2030
6.2.3 By Region - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Drugs Based on CAR T-cell Revenue, 2018-2030
6.3.2 US Drugs Based on CAR T-cell Market Size, 2018-2030
6.3.3 Canada Drugs Based on CAR T-cell Market Size, 2018-2030
6.3.4 Mexico Drugs Based on CAR T-cell Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Drugs Based on CAR T-cell Revenue, 2018-2030
6.4.2 Germany Drugs Based on CAR T-cell Market Size, 2018-2030
6.4.3 France Drugs Based on CAR T-cell Market Size, 2018-2030
6.4.4 U.K. Drugs Based on CAR T-cell Market Size, 2018-2030
6.4.5 Italy Drugs Based on CAR T-cell Market Size, 2018-2030
6.4.6 Russia Drugs Based on CAR T-cell Market Size, 2018-2030
6.4.7 Nordic Countries Drugs Based on CAR T-cell Market Size, 2018-2030
6.4.8 Benelux Drugs Based on CAR T-cell Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Drugs Based on CAR T-cell Revenue, 2018-2030
6.5.2 China Drugs Based on CAR T-cell Market Size, 2018-2030
6.5.3 Japan Drugs Based on CAR T-cell Market Size, 2018-2030
6.5.4 South Korea Drugs Based on CAR T-cell Market Size, 2018-2030
6.5.5 Southeast Asia Drugs Based on CAR T-cell Market Size, 2018-2030
6.5.6 India Drugs Based on CAR T-cell Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Drugs Based on CAR T-cell Revenue, 2018-2030
6.6.2 Brazil Drugs Based on CAR T-cell Market Size, 2018-2030
6.6.3 Argentina Drugs Based on CAR T-cell Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue, 2018-2030
6.7.2 Turkey Drugs Based on CAR T-cell Market Size, 2018-2030
6.7.3 Israel Drugs Based on CAR T-cell Market Size, 2018-2030
6.7.4 Saudi Arabia Drugs Based on CAR T-cell Market Size, 2018-2030
6.7.5 UAE Drugs Based on CAR T-cell Market Size, 2018-2030
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Drugs Based on CAR T-cell Major Product Offerings
7.1.4 Novartis Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Drugs Based on CAR T-cell Major Product Offerings
7.2.4 Gilead Sciences Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Major Product Offerings
7.3.4 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News
7.4 J & J
7.4.1 J & J Corporate Summary
7.4.2 J & J Business Overview
7.4.3 J & J Drugs Based on CAR T-cell Major Product Offerings
7.4.4 J & J Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.4.5 J & J Key News
7.5 JW Therapeutics
7.5.1 JW Therapeutics Corporate Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics Drugs Based on CAR T-cell Major Product Offerings
7.5.4 JW Therapeutics Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News
7.6 FOSUNKite
7.6.1 FOSUNKite Corporate Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite Drugs Based on CAR T-cell Major Product Offerings
7.6.4 FOSUNKite Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs Based on CAR T-cell Market Opportunities & Trends in Global Market
Table 2. Drugs Based on CAR T-cell Market Drivers in Global Market
Table 3. Drugs Based on CAR T-cell Market Restraints in Global Market
Table 4. Key Players of Drugs Based on CAR T-cell in Global Market
Table 5. Top Drugs Based on CAR T-cell Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs Based on CAR T-cell Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs Based on CAR T-cell Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs Based on CAR T-cell Product Type
Table 9. List of Global Tier 1 Drugs Based on CAR T-cell Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs Based on CAR T-cell Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Drugs Based on CAR T-cell Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs Based on CAR T-cell Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue, (US$, Mn), 2023-2030
Table 30. Novartis Corporate Summary
Table 31. Novartis Drugs Based on CAR T-cell Product Offerings
Table 32. Novartis Drugs Based on CAR T-cell Revenue (US$, Mn), (2018-2023)
Table 33. Gilead Sciences Corporate Summary
Table 34. Gilead Sciences Drugs Based on CAR T-cell Product Offerings
Table 35. Gilead Sciences Drugs Based on CAR T-cell Revenue (US$, Mn), (2018-2023)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Drugs Based on CAR T-cell Product Offerings
Table 38. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue (US$, Mn), (2018-2023)
Table 39. J & J Corporate Summary
Table 40. J & J Drugs Based on CAR T-cell Product Offerings
Table 41. J & J Drugs Based on CAR T-cell Revenue (US$, Mn), (2018-2023)
Table 42. JW Therapeutics Corporate Summary
Table 43. JW Therapeutics Drugs Based on CAR T-cell Product Offerings
Table 44. JW Therapeutics Drugs Based on CAR T-cell Revenue (US$, Mn), (2018-2023)
Table 45. FOSUNKite Corporate Summary
Table 46. FOSUNKite Drugs Based on CAR T-cell Product Offerings
Table 47. FOSUNKite Drugs Based on CAR T-cell Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Drugs Based on CAR T-cell Segment by Type in 2022
Figure 2. Drugs Based on CAR T-cell Segment by Application in 2022
Figure 3. Global Drugs Based on CAR T-cell Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs Based on CAR T-cell Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Drugs Based on CAR T-cell Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs Based on CAR T-cell Revenue in 2022
Figure 8. By Type - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
Figure 9. By Application - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
Figure 10. By Region - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
Figure 11. By Country - North America Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
Figure 12. US Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
Figure 16. Germany Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 17. France Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
Figure 24. China Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 28. India Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
Figure 30. Brazil Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue Market Share, 2018-2030
Figure 33. Turkey Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2030
Figure 37. Novartis Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Gilead Sciences Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. J & J Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. JW Therapeutics Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. FOSUNKite Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
